Related: Britney Spears’ Ups and Downs Over the Years
Advertisement
Britney Spears. Steve Granitz/WireImage
Britney Spears won’t be releasing new music anytime soon.
“I will never return to the music industry!!!” Spears, 42, wrote via Instagram on Wednesday, January 3. “When I write, I write for fun or I write for other people !!! For those of you who have read my book, there’s loads that you don’t know about me … I’ve written over 20 songs for other people the past two years !!!”
Spears, whose last album Glory dropped in 2016, noted that instead of stepping back into the spotlight for herself, she’s recently worked as a “ghostwriter” for other artists and “enjoys it that way.” The singer also slammed rumors that her 2023 memoir, The Woman in Me, was released “illegally” without her approval, calling the speculation “far from the truth.”
The pop star has been taking her life into her own hands since her 13-year conservatorship ended in November 2021. Britney’s father, Jamie Spears, was first appointed the conservator of her personal life, finances and more starting in 2008. Britney began advocating for the termination of the conservatorship in 2021, alleging that Jamie, 71, and co-conservator Jodi Montgomery — who took over in 2019 — had abused their positions.
The Woman in Me, which hit shelves in October 2023, detailed Britney’s ups and downs since being thrust into the public eye, including what led up to her conservatorship being put into place. In the book, Britney wrote that she she knew “[she] had been acting wild” and partying at the height of her early 2000’s fame, but did not think that warranted such a strong reaction from her family.
Kevin Winter/Getty Images
“There was nothing I’d done that justified their treating me like I was a bank robber. Nothing that justified upending my entire life,” she alleged. “I went from partying a lot to being a total monk. Security guards handed me prepackaged envelopes of meds and watched me take them. They put parental controls on my iPhone. Everything was scrutinized and controlled. Everything.”
It was that tight control placed upon her, she explained, that has now led her to posting frequently and candidly on social media. Since the end of her conservatorship, Britney has taken to Instagram to perform dances for her fans, seemingly call out ex-boyfriend Justin Timberlake, share memories with her sons and give a glimpse into her life as a newly single woman after estranged husband Sam Asghari filed for divorce in August 2023. (Britney shares Sean Preston, 18, and Jayden James, 17, with ex-husband Kevin Federline.)
“I know that a lot of people don’t understand why I love taking pictures of myself naked or in new dresses,” she wrote. “But I think if they’d been photographed by other people thousands of times, prodded and posed for other people’s approval, they’d understand that I get a lot of joy from posing the way I feel sexy and taking my own picture, doing whatever I want with it.”
Britney Spears won’t be releasing new music anytime soon. “I will never return to the music industry!!!” Spears, 42, wrote via Instagram on Wednesday, January 3. “When I write, I write for fun or I write for other people !!! For those of you who have read my book, there’s loads that you don’t know
Us Weekly Read More

The film industry is entering a new body era, and this time, the co-star is a syringe.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have moved from diabetes clinics into casting conversations, red carpets, and agency strategy. In the United States, roughly 1 in 8 adults report having used a GLP-1 drug, with about 6 to 12 percent actively using one today. Globally, usage has surged from approximately 4 million people in 2020 to around 30 million by 2026.
This is no longer a niche health trend. It is a structural shift—one that is reshaping how bodies are constructed, perceived, and rewarded on screen.

At a clinical level, the appeal is clear. In major obesity trials, semaglutide has produced average weight loss of 15 to 17 percent of total body weight over 68 to 104 weeks, with some regimens approaching 19 to 21 percent for sustained users. In an industry built on transformation, those numbers carry real influence.
But rapid transformation leaves a visible trace. The phenomenon often called “Ozempic face”—hollowed cheeks, looser skin, a subtly aged appearance—reflects how quickly fat loss can outpace the skin’s ability to adjust.
For filmmakers, this is not just aesthetic—it is cinematic. Performance lives in the face. Micro-expressions, softness, and facial volume shape how emotion reads on camera. A performer may reach an “ideal” body while losing something less measurable but equally important on screen.
Beneath this cultural shift lies an origin story that feels almost written for film.
In the 1990s, researchers studying the Gila monster isolated a peptide in its venom called exendin-4, which mimicked a human hormone involved in blood sugar regulation but lasted significantly longer in the body. That discovery led to early GLP-1 drugs such as exenatide, used by millions of patients worldwide, and eventually to semaglutide.
By mid-2025, semaglutide-based drugs (including Ozempic and Wegovy) generated approximately $16 to $17 billion in just six months, making it one of the highest-grossing drug classes globally. Analysts project the broader incretin market could reach $200 billion annually by 2030.
Inside those numbers is a more complex human story.
The benefits are well documented: improved blood sugar control, significant weight loss, and reduced cardiovascular risk. But as use expands, so does scrutiny. Researchers and regulators are tracking side effects ranging from severe gastrointestinal issues and gastroparesis to gallbladder disease and pancreatitis, as well as rarer concerns such as vision complications and potential neurological signals.
At the same time, adoption continues to accelerate. J.P. Morgan projects roughly 10 million Americans on GLP-1 drugs by 2025, rising toward 25 to 30 million by 2030. At that scale, usage becomes ambient—part of everyday life across industries, including film and television.
And yet the marketing tells a different story. Pharmaceutical campaigns rely on cinematic language—aspirational visuals, controlled lighting, emotional transformation arcs—while legally required risk disclosures recede into fine print.
For independent filmmakers, this moment opens several narrative lanes.
There is the body: performers navigating an industry where a once-niche diabetes drug has become a quiet career tool.
There is the machine: a pharmaceutical ecosystem where a single drug category generates tens of billions annually, rivaling major entertainment sectors.
And there is the myth: a culture increasingly turning to a hormone-based intervention—derived from venom biology—rather than addressing systemic issues like food access, stress, and inequality.
Technology intensifies all of it. Ultra-high-resolution cameras and HDR workflows capture every detail—skin texture, volume shifts, micro-expressions. As more on-screen talent uses the same class of drugs, a new visual baseline begins to form, often without audiences realizing why.
There is also a clear economic divide. GLP-1 drugs can cost $800 to $1,000 or more per month without insurance in the United States, and coverage remains inconsistent. Rising demand has led to shortages and a parallel market of compounded or unregulated alternatives.

The gap between who can access consistent, medically supervised treatment and who cannot is becoming part of the story itself.
For cinema, the imagery is already there: the Sonoran desert, a Gila monster, laboratory research, pharmaceutical earnings calls, red carpets, and transformation narratives.
A compound derived from venom becomes a global product that reshapes not only bodies, but expectations.
Perhaps the most uncomfortable layer is the industry’s own role. Casting preferences, transformation culture, and unspoken aesthetic standards reinforce a pharmacological look without ever naming it.
No one explicitly instructs performers to take these drugs. The system simply rewards the results.
This is not a distant trend. It is a present-tense shift.
The numbers are rising. The images are changing. The influence is expanding.
The question is whether independent cinema will define this moment while it is still unfolding—or whether the story will once again be shaped by the industries profiting most from it.

Every filmmaker aspires to create projects that are not only memorable but also uniquely their own. Finding your creative voice is a journey that requires self-reflection, bold choices, and an unwavering commitment to your vision. Here’s how to uncover your style, take risks, and craft original work that stands out.
Your unique voice begins with recognizing what inspires you.
Tip: Combine what you love with your personal experiences to create a lens that only you can offer.
Example: Wes Anderson’s whimsical, symmetrical worlds stem from his love of classic storytelling and his unique visual style.
Takeaway: Start with what moves you, then add your personal touch.
To stand out, you must be willing to challenge conventions and explore new territory.
Example: Jordan Peele blended horror with social commentary in Get Out, creating a genre-defying film that captivated audiences.
Takeaway: Risks are an opportunity for growth, even if they don’t always succeed.
Original projects resonate when they stem from a place of truth.
Example: Greta Gerwig’s Lady Bird was deeply personal, based on her experiences growing up in Sacramento. The film’s authenticity made it universally relatable.
Takeaway: The more personal the story, the more it resonates.
Style is not just about visuals—it’s how you tell a story across all elements of filmmaking.
Example: Quentin Tarantino’s use of dialogue, pop culture references, and bold music choices makes his work instantly recognizable.
Takeaway: Your style should be intentional, evolving as you grow but always recognizable as yours.
The filmmaking process is full of challenges, but staying true to your voice is essential.
Example: Ava DuVernay shifted from public relations to filmmaking, staying true to her voice in films like Selma and 13th, which focus on social justice.
Takeaway: Your voice evolves with every project, so embrace the process.
Finding your voice as a filmmaker takes time, courage, and commitment. By exploring your influences, taking risks, and staying true to your perspective, you’ll craft stories that not only stand out but also resonate deeply with your audience.
Bolanle Media is excited to announce our partnership with The Newbie Film Academy to offer comprehensive courses designed specifically for aspiring screenwriters. Whether you’re just starting out or looking to enhance your skills, our resources will provide you with the tools and knowledge needed to succeed in the competitive world of screenwriting. Join us today to unlock your creative potential and take your first steps toward crafting compelling stories that resonate with audiences. Let’s turn your ideas into impactful scripts together!

The Michael Jackson biopic Michael is more than celebrity drama; it is a real-time lesson in how legal decisions can quietly rewrite a story that millions of people will see. You do not need a $200M budget for the same forces—contracts, settlements, and rights issues—to shape or even erase key parts of your own work.

The film Michael originally included a third act that addressed the 1993 child sexual abuse allegations and their impact on Jackson’s life and career. Trade reports say this version showed investigators at Neverland Ranch and dramatized the scandal as a turning point in the story. After cameras rolled, lawyers for the Jackson estate realized there was a clause in the settlement with accuser Jordan Chandler that barred any depiction or mention of him in a movie.
Because of that old agreement, the filmmakers had to remove all references to Chandler and rework the ending so the story stopped years earlier, in the late 1980s at Jackson’s commercial peak.
According to reporting, this meant roughly 22 days of reshoots, costing around 10–15 million dollars and pushing the total budget over 200 million.
Meanwhile, actress Kat Graham confirmed her portrayal of Diana Ross was cut for “legal considerations,” showing how likeness and approval issues can wipe out an entire character even after filming.
For audiences, the result is a movie that intentionally avoids one of the most controversial chapters of Jackson’s life, which some critics argue makes the portrait feel incomplete or selectively curated.
The key detail in the Michael story is that a contract signed decades ago could dictate what present-day filmmakers are allowed to show. That settlement clause did not just affect the people who signed it; it effectively controlled the narrative of a big-budget film made years later. This is how legal documents become invisible co-authors: they quietly set boundaries around what your story can and cannot include.
Creators face similar invisible lines with:
Legal commentary warns that fictionalizing real events and people carries heightened risk because audiences tend to connect your dramatization back to actual individuals. That risk does not disappear just because you are “small” or “indie”; impact, not audience size, usually determines exposure.
Independent filmmakers often choose the indie route precisely to maintain creative control, but they can face more risk if they skip legal planning. Common problems include unclear ownership of the script, missing music licenses, handshake agreements with collaborators, and no written permission to use locations or people’s likenesses. These are the kinds of issues that can derail distribution, block a streaming deal, or force last-minute cuts that fundamentally change your story.
Legal guides for indie filmmakers consistently emphasize a few realities:
So when you watch Michael skip over certain events, you are seeing, in exaggerated form, the same forces that can shape an indie short, web series, documentary, or podcast episode.
You do not need a law degree, but you do need a basic legal strategy for your creative work. Here are practical steps drawn from entertainment-law and indie-film resources:
Education-focused legal resources repeatedly stress that preventative steps—basic contracts, clear permissions, and simple registrations—are far cheaper than dealing with takedowns, lawsuits, or forced rewrites later.
The Michael biopic illustrates what happens when legal obligations and creative vision collide: whole characters disappear, endings are rewritten, and the public only sees a version of the story that fits within old contracts.
As an indie filmmaker, writer, or content creator, you may not have millions at stake, but you do have something just as valuable—your voice and your ability to tell the story you meant to tell.
Understanding the legal dimensions of your work is not a distraction from creativity; it is a way of protecting it. When you know where the legal boundaries are, you can design stories that are bold, truthful, and still safe enough to reach the audiences they deserve.

How to Make Your Indie Film Pay Off Without Losing Half to Distributors

How to Find Your Voice as a Filmmaker

FIPRM Expands Into Sports, Partners With Bolanle Media to Launch New Media Platform

What the Michael Biopic Means for Every Indie Filmmaker

Mother’s Day AfroFun Praise Party: Gospel Dance, Fitness & Feel‑Good Stats in 60 Minutes

GLOBAL SUSTAINABILITY SUMMIT RETURNS FOR ITS 5TH EDITION AT THE BRITISH PARLIAMENT – HOUSE OF LORDS, PALACE OF WESTMINSTER

Can AI Really Steal Your Fingerprints From a Selfie?

Actors Win AI Deal – But Your Face Is Still Training the Machine